Ovarian Damage during Chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility
Women with autoimmune diseases such as lupus, scleroderma, and vasculitis receiving cyclophosphamide for severe disease manifestations risk primary ovarian insufficiency (POI) due to gonadotoxicity of this therapy. In addition to loss of reproductive potential, POI is associated with increased risk...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2012-01-01
|
| Series: | Clinical Medicine Insights: Reproductive Health |
| Online Access: | https://doi.org/10.4137/CMRH.S10415 |